Use of adenovirus type-5 vectored vaccines : a cautionary tale
| Errataetall: |
CommentOn: Lancet. 2020 Jun 13;395(10240):1845-1854. - PMID 32450106 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:396 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 396(2020), 10260 vom: 31. Okt., Seite e68-e69 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Buchbinder, Susan P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adenovirus Vaccines |
|---|
| Anmerkungen: |
Date Completed 11.11.2020 Date Revised 26.04.2022 published: Print-Electronic CommentOn: Lancet. 2020 Jun 13;395(10240):1845-1854. - PMID 32450106 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(20)32156-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316602744 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316602744 | ||
| 003 | DE-627 | ||
| 005 | 20231225161438.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(20)32156-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM316602744 | ||
| 035 | |a (NLM)33091364 | ||
| 035 | |a (PII)S0140-6736(20)32156-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Buchbinder, Susan P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of adenovirus type-5 vectored vaccines |b a cautionary tale |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.11.2020 | ||
| 500 | |a Date Revised 26.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Lancet. 2020 Jun 13;395(10240):1845-1854. - PMID 32450106 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adenovirus Vaccines |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines, Synthetic |2 NLM | |
| 650 | 7 | |a Viral Vaccines |2 NLM | |
| 700 | 1 | |a McElrath, M Juliana |e verfasserin |4 aut | |
| 700 | 1 | |a Dieffenbach, Carl |e verfasserin |4 aut | |
| 700 | 1 | |a Corey, Lawrence |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 396(2020), 10260 vom: 31. Okt., Seite e68-e69 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:396 |g year:2020 |g number:10260 |g day:31 |g month:10 |g pages:e68-e69 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(20)32156-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 396 |j 2020 |e 10260 |b 31 |c 10 |h e68-e69 | ||